Reagent Shop Altogen Begins Looking to Apply Technologies to Therapeutic siRNA Delivery

Altogen's drug-delivery efforts are being conducted within "a very small program," however, and the company's main interest, at least for now, remains in "offering [its technologies] as tools for customers," according to an official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.